Suppr超能文献

来自福尔马林固定石蜡包埋样本的胃癌患者的微小RNA分析

MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples.

作者信息

Osawa Soshi, Shimada Yutaka, Sekine Shinichi, Okumura Tomoyuki, Nagata Takuya, Fukuoka Junya, Tsukada Kazuhiro

机构信息

Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan.

出版信息

Oncol Lett. 2011 Jul;2(4):613-619. doi: 10.3892/ol.2011.313. Epub 2011 May 13.

Abstract

MicroRNA (miRNA) is a small non-coding RNA that targets specific mRNA. Recent progress in the extraction of RNA from formalin-fixed paraffin-embedded (FFPE) tissues has facilitated miRNA profiling using samples stored in laboratories worldwide. In the present study, miRNA profiling of gastric cancer patients is determined using FFPE samples. First, criteria were established for determining evaluable RNA from the FFPE samples. miRNA profiling was then undertaken using miRNA oligo chips with 885 featured genes. The FFPE samples were obtained from 47 gastric cancer patients who underwent operations between 1997 and 2007. Results showed that out of 47 paired samples, 37 pairs (78.8%) were evaluable by our criteria. A total of 30 miRNAs were significantly up-regulated and 11 miRNAs were down-regulated in gastric cancer compared with those in normal gastric tissue. Among these, 14 miRNAs, including miR-21, were identified as prognostic factors of gastric cancer patients. Furthermore, miR-34a was selected as an independent prognostic factor. In conclusion, we identified miRNAs that are associated with the prognosis of gastric cancer patients. miRNA profiling using FFPE samples is a useful and promising method of evaluation for samples stored in laboratories worldwide, and can generate extremely valuable clinical data.

摘要

微小RNA(miRNA)是一种靶向特定信使核糖核酸(mRNA)的小型非编码RNA。从福尔马林固定石蜡包埋(FFPE)组织中提取RNA的最新进展推动了利用全球实验室中保存的样本进行miRNA谱分析。在本研究中,使用FFPE样本对胃癌患者进行miRNA谱分析。首先,建立了从FFPE样本中确定可评估RNA的标准。然后使用具有885个特征基因的miRNA寡核苷酸芯片进行miRNA谱分析。FFPE样本取自1997年至2007年间接受手术的47例胃癌患者。结果显示,在47对配对样本中,根据我们的标准有37对(78.8%)可评估。与正常胃组织相比,共有30种miRNA在胃癌中显著上调,11种miRNA下调。其中,包括miR-21在内的14种miRNA被确定为胃癌患者的预后因素。此外,miR-34a被选为独立预后因素。总之,我们鉴定出了与胃癌患者预后相关的miRNA。使用FFPE样本进行miRNA谱分析是一种对全球实验室中保存的样本进行评估的有用且有前景的方法,并且能够产生极具价值的临床数据。

相似文献

引用本文的文献

7
Prognostic value of microRNAs in gastric cancer: a meta-analysis.微小RNA在胃癌中的预后价值:一项荟萃分析。
Oncotarget. 2017 Jun 21;8(33):55489-55510. doi: 10.18632/oncotarget.18590. eCollection 2017 Aug 15.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验